New drug mimics IVIg to tame nerve inflammation
Disease control
Ongoing
This study tests a new drug called NVG-2089 in 60 adults with CIDP, a chronic nerve condition that causes weakness and numbness. The drug is designed to calm the immune system, similar to IVIg therapy. Researchers will check if it is safe and if it helps improve symptoms over 14 …
Phase: PHASE2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC